160 related articles for article (PubMed ID: 18186495)
21. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.
Porceddu SV; Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Foote MC; Panizza B; Coman S; McFarlane D; Coman W
Head Neck; 2011 Dec; 33(12):1675-82. PubMed ID: 22076976
[TBL] [Abstract][Full Text] [Related]
22. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary?
Johnson CR; Silverman LN; Clay LB; Schmidt-Ullrich R
Radiat Oncol Investig; 1998; 6(1):52-7. PubMed ID: 9503489
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
[TBL] [Abstract][Full Text] [Related]
25. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
[TBL] [Abstract][Full Text] [Related]
27. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
[TBL] [Abstract][Full Text] [Related]
28. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Mendenhall WM; Villaret DB; Amdur RJ; Hinerman RW; Mancuso AA
Head Neck; 2002 Nov; 24(11):1012-8. PubMed ID: 12410537
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
30. Less may be more: nodal treatment in neck positive head neck cancer patients.
Studer G; Huber GF; Holz E; Glanzmann C
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1549-56. PubMed ID: 25920604
[TBL] [Abstract][Full Text] [Related]
31. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.
Lyford-Pike S; Ha PK; Jacene HA; Saunders JR; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):251-6. PubMed ID: 19776658
[TBL] [Abstract][Full Text] [Related]
32. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
33. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
34. Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Langerman A; Plein C; Vokes EE; Salama JK; Haraf DJ; Blair EA; Stenson KM
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1133-6. PubMed ID: 19917927
[TBL] [Abstract][Full Text] [Related]
35. Controversies in surgical management of the node-positive neck after chemoradiation.
Lango MN; Myers JN; Garden AS
Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
[TBL] [Abstract][Full Text] [Related]
36. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
37. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.
Nevens D; Vantomme O; Laenen A; Hermans R; Nuyts S
Cancer Imaging; 2017 Feb; 17(1):8. PubMed ID: 28241854
[TBL] [Abstract][Full Text] [Related]
39. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
40. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
Lim YC; Koo BS; Lee JS; Choi EC
Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
